Physician profile
Christopher Whelan
NPI 1275745267
$3,010.62
in general payments reported to CMS, 2019-2025
28 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $51.93 · 2021: $233 · 2022: $292 · 2023: $487 · 2024: $270 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248 · Travel and Lodging: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.53 |
| Travel and Lodging | $795.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,045.90 | 2025 | |
| Astellas Pharma US INC | $329.15 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $279.78 | 2023 | Prolaris |
| Dendreon Pharmaceuticals LLC | $174.04 | 2019-2021 | |
| Cook Medical LLC | $138.90 | 2019 | |
| Verity Pharmaceuticals INC. | $130.86 | 2022-2024 | Trelstar |
| Abbvie INC. | $109.66 | 2021-2025 | |
| Coloplast Corp | $88.17 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $82.75 | 2023-2024 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $66.90 | 2024-2025 | Lithovue, Ams 800 Artificial Urinary Sphincter |
| Tempus Ai, INC | $66.86 | 2024-2025 | Xt Cdx |
| Rochester Medical Corporation | $61.21 | 2022 | |
| Myovant Sciences INC. | $57.03 | 2022 | |
| 180 Medical, INC. | $50.28 | 2022-2024 | Gentlecath Glide |
| Angiodynamics, INC. | $48.74 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $41.35 | 2024 | |
| Olympus America INC. | $34.60 | 2022-2025 | Itind System |
| Blue Earth Diagnostics | $32.79 | 2021 | |
| Medtronic, INC. | $25.15 | 2023 | Interstim |
| Allergan, INC. | $24.17 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $18.09 | 2022 | |
| Urogen Pharma, INC. | $17.99 | 2021 | |
| Travere Therapeutics, INC. | $17.05 | 2019 | |
| Koelis INC. | $16.14 | 2023 | |
| Dentsply Ih INC. | $14.79 | 2019 | |
| Cardinal Health 414 LLC | $13.47 | 2023 | |
| Pfizer INC. | $13.37 | 2020 | |
| Convatec INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.